Trv Gp Iv, LLC Tango Therapeutics, Inc. Transaction History
Trv Gp Iv, LLC
- $88.8 Million
- Q2 2025
A detailed history of Trv Gp Iv, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Trv Gp Iv, LLC holds 16,859,075 shares of TNGX stock, worth $111 Million. This represents 97.21% of its overall portfolio holdings.
Number of Shares
16,859,075
Previous 16,859,075
-0.0%
Holding current value
$111 Million
Previous $23.1 Million
273.74%
% of portfolio
97.21%
Previous 88.92%
Shares
3 transactions
Others Institutions Holding TNGX
# of Institutions
125Shares Held
98.3MCall Options Held
1.1KPut Options Held
2.7K-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$71 Million3.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$70.3 Million1.14% of portfolio
-
Nextech Invest Ag5.53MShares$36.6 Million3.19% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$36.6 Million1.76% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.61MShares$30.5 Million0.04% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $582M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...